|
Kazia Corporate Update and Corporate Presentation
|
26 June 2023 at 9:45am
|
|
Launch of LUMOS2 Study
|
8 June 2023 at 8:50am
|
|
Constitution
|
7 June 2023 at 2:35pm
|
|
Appointment of Non-executive Director
|
5 June 2023 at 9:25am
|
|
Kazia CEO participates in White House Cancer Moonshot Forum
|
26 May 2023 at 9:05am
|
|
Cancel - Notification of cessation of securities - KZA
|
25 May 2023 at 4:45pm
|
|
Quarterly Activities/Appendix 4C Cash Flow Report - updated
|
9 May 2023 at 4:55pm
|
|
Notification regarding unquoted securities - KZA
|
8 May 2023 at 2:05pm
|
|
Notification of cessation of securities - KZA
|
5 May 2023 at 10:30am
|
|
Final Director's Interest Notice - Dr J Garner
|
2 May 2023 at 3:20pm
|
|
Executive Leadership changes - Dr John Friend appointed CEO
|
1 May 2023 at 8:40am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 April 2023 at 9:25am
|
|
Kazia regains compliance with Nasdaq minimum bid requirement
|
14 April 2023 at 8:45am
|
|
Notification of cessation of securities - KZA
|
12 April 2023 at 4:35pm
|
|
Change in substantial holding
|
6 April 2023 at 8:40am
|
|
Kazia presents new data at AACR Annual Meeting
|
4 April 2023 at 8:40am
|
|
Change of Director's Interest Notice
|
21 March 2023 at 10:45am
|
|
Change of Director's Interest Notice
|
17 March 2023 at 9:05am
|
|
Notification of cessation of securities - KZA
|
8 March 2023 at 10:25am
|
|
Clinical Collaboration for Phase II clinical study
|
7 March 2023 at 8:40am
|
|
Change in substantial holding
|
7 March 2023 at 8:40am
|
|
Change in substantial holding
|
6 March 2023 at 4:50pm
|
|
Change of Director's Interest Notices
|
6 March 2023 at 11:40am
|
|
Notification regarding unquoted securities - KZA
|
6 March 2023 at 11:20am
|
|
Cleansing Notice
|
3 March 2023 at 1:10pm
|
|
Application for quotation of securities - KZA
|
3 March 2023 at 10:15am
|
|
Change in substantial holding
|
2 March 2023 at 8:45am
|
|
Resignation and appointment of Company Secretary
|
28 February 2023 at 4:45pm
|
|
Half Yearly Report and Accounts
|
28 February 2023 at 1:55pm
|
|
Kazia result of Share Purchase Plan
|
28 February 2023 at 10:05am
|
|
Cleansing notice
|
28 February 2023 at 9:55am
|
|
Application for quotation of securities - KZA
|
28 February 2023 at 9:50am
|
|
Results of EGM
|
24 February 2023 at 5:05pm
|
|
Details of Auditor Appointment/Resignation
|
24 February 2023 at 8:50am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
15 February 2023 at 5:40pm
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 January 2023 at 9:15am
|
|
Substantial shareholder notice
|
24 January 2023 at 10:05am
|
|
Kazia Share Purchase Plan
|
19 January 2023 at 8:45am
|
|
Notice of Extraordinary General Meeting/Proxy Form
|
19 January 2023 at 8:40am
|
|
Change in substantial holding
|
18 January 2023 at 4:10pm
|
|
Change in substantial holding
|
18 January 2023 at 8:45am
|
|
Cleansing notice
|
17 January 2023 at 5:05pm
|
|
Cleansing notice
|
17 January 2023 at 5:05pm
|
|
Application for quotation of securities - KZA
|
17 January 2023 at 4:50pm
|
|
Application for quotation of securities - KZA
|
17 January 2023 at 4:45pm
|
|
Proposed issue of securities - KZA
|
17 January 2023 at 10:40am
|
|
Proposed issue of securities - KZA
|
16 January 2023 at 9:55am
|
|
Kazia raises $4.5m and launches share purchase plan
|
16 January 2023 at 9:55am
|
|
Trading Halt
|
12 January 2023 at 9:30am
|
|
Kazia pre-clinical collaboration with QIMR
|
15 December 2022 at 9:55am
|
